Caroline Cella
Family Medicine · North Chesterfield, VANPI 1679522098
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations.
Across 179 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$358
- AstraZeneca$311
- AbbVie$248
- Pfizer$196
- GSK$191
- Lilly USA, LLC$190
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,592100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $358 |
| AstraZeneca | 20 | $311 |
| AbbVie(2 entities) | 19 | $248 |
| Pfizer | 19 | $196 |
| GSK | 11 | $191 |
| Lilly USA, LLC | 15 | $190 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $132 |
| Amgen | 9 | $120 |
| Abbott | 5 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $108 |
| Boehringer Ingelheim | 6 | $105 |
| Astellas Pharma US Inc | 6 | $91 |
| Bayer | 5 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| Merck | 3 | $40 |
| Scilex Pharmaceuticals Inc. | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 1 | $28 |
| Esperion Therapeutics, Inc. | 2 | $26 |
| Eisai Inc. | 1 | $22 |
| Boston Scientific | 1 | $19 |
| Novartis | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $19 |
| Biogen | 1 | $16 |
| Concordia Pharmaceuticals Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$2,598 in reported general payments places this provider in the 80th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in North Chesterfield
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.